On May 27, 2024, Pangenomic Health Inc., closed the transaction. The company issued 21,502,320 units of the company at a price of CAD 0.05 per unit for the gross proceeds of CAD 1,075,116. The securities issued pursuant to the Offering are subject to a four month plus one day hold period under applicable Canadian securities laws.